http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014249218-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca79dd45db01898a1c13c975110324c9 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-22 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22 |
filingDate | 2014-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be4ff1968147769ffae3888c0a37c5af |
publicationDate | 2014-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2014249218-A1 |
titleOfInvention | Administration of ingenol mebutate |
abstract | The present invention relates to novel crystalline forms of ingenol ingenol-3-angelate and methods of preparation and use thereof. More specifically, the invention relates to a novel crystalline form and purified forms of the compound of Formula 1 (ingenol-3-mebutate; ingenol-3-angelate; isoform ‘b’; PEP005), which is characterized by, for example, attenuated total reflectance Fourier transform infrared (FTIR-ATR) spectroscopy, single crystal X-Ray crystallography (XRC), X-ray powder diffraction, and, Differential Scanning Calorimetry (DSC), and methods of preparation and use thereof. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9713608-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015265567-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9526714-B2 |
priorityDate | 2013-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 306.